Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Entrada Therapeutics (TRDA)

Entrada Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:TRDA
DateTimeSourceHeadlineSymbolCompany
24/06/202412:15GlobeNewswire Inc.Entrada Therapeutics Announces $100 Million Registered Direct OfferingNASDAQ:TRDAEntrada Therapeutics Inc
24/06/202411:00GlobeNewswire Inc.Entrada Therapeutics Reports Positive Preliminary Data in Healthy Volunteers from Phase 1 ENTR-601-44-101 Trial for Duchenne Muscular DystrophyNASDAQ:TRDAEntrada Therapeutics Inc
14/06/202421:34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TRDAEntrada Therapeutics Inc
14/06/202421:33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TRDAEntrada Therapeutics Inc
13/06/202421:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TRDAEntrada Therapeutics Inc
03/06/202412:00GlobeNewswire Inc.Entrada Therapeutics to Present at Goldman Sachs 45th Annual Global Healthcare ConferenceNASDAQ:TRDAEntrada Therapeutics Inc
20/05/202422:26Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TRDAEntrada Therapeutics Inc
16/05/202421:18Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TRDAEntrada Therapeutics Inc
16/05/202412:00GlobeNewswire Inc.Entrada Therapeutics to Present at H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQNASDAQ:TRDAEntrada Therapeutics Inc
07/05/202412:10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TRDAEntrada Therapeutics Inc
07/05/202412:04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TRDAEntrada Therapeutics Inc
07/05/202412:00GlobeNewswire Inc.Entrada Therapeutics Reports First Quarter 2024 Financial ResultsNASDAQ:TRDAEntrada Therapeutics Inc
13/03/202411:00GlobeNewswire Inc.Entrada Therapeutics Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:TRDAEntrada Therapeutics Inc
08/03/202421:36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TRDAEntrada Therapeutics Inc
08/03/202421:34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TRDAEntrada Therapeutics Inc
06/03/202421:22Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TRDAEntrada Therapeutics Inc
06/03/202421:22Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TRDAEntrada Therapeutics Inc
06/03/202400:47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TRDAEntrada Therapeutics Inc
06/03/202400:46Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TRDAEntrada Therapeutics Inc
06/03/202400:44Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TRDAEntrada Therapeutics Inc
07/02/202412:00GlobeNewswire Inc.Entrada Therapeutics to Present at Upcoming Investor ConferencesNASDAQ:TRDAEntrada Therapeutics Inc
03/01/202412:16Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TRDAEntrada Therapeutics Inc
03/01/202412:00GlobeNewswire Inc.Entrada Therapeutics Promotes Nathan J. Dowden to PresidentNASDAQ:TRDAEntrada Therapeutics Inc
26/12/202321:35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TRDAEntrada Therapeutics Inc
21/12/202321:26Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TRDAEntrada Therapeutics Inc
06/12/202312:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TRDAEntrada Therapeutics Inc
22/11/202316:56Dow Jones NewsEntrada Therapeutics Shares Tumble 27% After FDA Keeps Clinical HoldNASDAQ:TRDAEntrada Therapeutics Inc
22/11/202312:54Dow Jones NewsEntrada: FDA Declines to Lift Hold on Duchenne StudyNASDAQ:TRDAEntrada Therapeutics Inc
22/11/202312:35Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TRDAEntrada Therapeutics Inc
22/11/202312:00GlobeNewswire Inc.Entrada Therapeutics Announces Updates on ENTR-601-44 in Duchenne Muscular DystrophyNASDAQ:TRDAEntrada Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:TRDA

Your Recent History

Delayed Upgrade Clock